GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CVR Medical Corp (OTCPK:CRRVF) » Definitions » Return-on-Tangible-Equity

CVR Medical (CVR Medical) Return-on-Tangible-Equity : 0.00% (As of Sep. 2022)


View and export this data going back to 2016. Start your Free Trial

What is CVR Medical Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. CVR Medical's annualized net income for the quarter that ended in Sep. 2022 was $-1.04 Mil. CVR Medical's average shareholder tangible equity for the quarter that ended in Sep. 2022 was $-4.76 Mil. Therefore, CVR Medical's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2022 was N/A%.

The historical rank and industry rank for CVR Medical's Return-on-Tangible-Equity or its related term are showing as below:

CRRVF's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.97
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

CVR Medical Return-on-Tangible-Equity Historical Data

The historical data trend for CVR Medical's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVR Medical Return-on-Tangible-Equity Chart

CVR Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,733.33 - - - -

CVR Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CVR Medical's Return-on-Tangible-Equity

For the Medical Devices subindustry, CVR Medical's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVR Medical's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVR Medical's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where CVR Medical's Return-on-Tangible-Equity falls into.



CVR Medical Return-on-Tangible-Equity Calculation

CVR Medical's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2021 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2021 )  (A: Dec. 2020 )(A: Dec. 2021 )
=-1.818/( (-3.839+-4.456 )/ 2 )
=-1.818/-4.1475
=N/A %

CVR Medical's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2022 )  (Q: Jun. 2022 )(Q: Sep. 2022 )
=-1.036/( (-4.695+-4.815)/ 2 )
=-1.036/-4.755
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2022) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


CVR Medical  (OTCPK:CRRVF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


CVR Medical Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of CVR Medical's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CVR Medical (CVR Medical) Business Description

Traded in Other Exchanges
N/A
Address
221 West Esplanade, c/o Suite 409, North Vancouver, Vancouver, BC, CAN, V7M 3J3
CVR Medical Corp is a medical device company. The company commercializing its Carotid Stenotic Scan (CSS), a patented, diagnostic tool that utilizes subsonic, infrasonic, and low-frequency sound wave analysis technology to detect and measure carotid arterial stenosis.

CVR Medical (CVR Medical) Headlines

No Headlines